Development and in vivo assessment of a transdermal system for physostigmine

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 20, Issue 6, 1998, Pages 489-498

  Benech, H ^a,b   Vincenti, M ^a   Fouchart, F ^a   Pruvost, A ^a   Vienet, R ^a   Istin, M ^a   Grognet, J M ^a  

^a CEA SACLAY   (France)

^b Institut National de la Recherche Agronomique   (France)

Author keywords

Assay; Development; Pharmacokinetics; Physostigmine; Transdermal

Indexed keywords

CHOLINESTERASE INHIBITOR; PHYSOSTIGMINE;

ANIMAL CELL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CHOLINESTERASE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; QUANTITATIVE DIAGNOSIS; RABBIT; VALIDATION PROCESS;

ADMINISTRATION, TOPICAL; ANIMALS; AREA UNDER CURVE; CHOLINESTERASE INHIBITORS; DRUG DELIVERY SYSTEMS; HALF-LIFE; MALE; PHYSOSTIGMINE; RABBITS; SKIN;

EID: 0031662033     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.1998.20.6.485712     Document Type: Article

References (28)

1. Unni, L.K., Hannant, M.E., Becker, R.E., Giacobini, E. Determination of physostigmine in plasma and cerebrospinal fluid by liquid chromatography with electrochemical detection. Clin Chem 1989, 35: 292-285.
2. Somani, S.M., Gupta, S.K., Khalique, A., Unni, L.K. Physiological. pharmacokinetic and pharmacodynamic model of physostigmine in the rat. Drug Metab Dispos 1991, 19: 655-60.
3. Somani, S.M., Dube, S.N. Physostigmine-an overview as pretreatment drug for organophosphate intoxication. Int J Clin Pharm Ther Tox 1989, 27: 367-87.
4. Davis, K.L., Mohs, R.C. Enhancement of memory processes in Alzheimer's disease with multiple dose intravenous physostigmine. Am J Psychiat 1982, 139: 1421-4.
5. Harris, L.W., Talbot, B.C., Lennox, W.J., Anderson, D.R., Solana, R.P. Physostigmine (alone or together with adjunct) pretreatment against soman, sarin, tabun and VX intoxication. Drug Chem Toxicol 1991, 14: 265-81.
6. Miller, S.A., Blick, D.W., Kerenyi, S.Z., Murphy, M.R. Efficacy of physostigmine as a pretreatment for organophosphate poisoning. Pharmacol Biochem Behav 1993, 44: 343-7.
7. Benita, S., Friedman, D., Pathak, Y.V., Kleinstem, J. Micronized emulsion for controlled release of physostigmine after oral administration, Part II. Release characteristics and pharmacological evaluation. Drug Design Deliv 1989, 4: 143-53.
8. Knapp, S., Wardlow, M.L., Albert, K., Waters, D., Thal, L.J. Correlation between plasma physostigmine concentrations and percentage of acetylcholinesterase inhibition over time after controlled release of physostigmine in volunteer subjects. Drug Metab Dispos 1991, 19: 400-4.
9. Lau, S.W.J., Chow, D., Feldman, S. Simultaneous determination of physostigmine and tetrahydro acridine in a TD permeation study high performance liquid Chromatography. J Chrom 1990, 526: 87-95.
10. Levy, D., Glikfeld, P., Grunfeld, Y. et al. A novel TD therapeutic system as a potential treatment for Alzheimer's disease. Adv Behav Biol 1986, 29: 557-63.
11. Meshulam, Y., Kadar, T., Wengier, A., Dachir, S., Levy, A. TD penetration of physostigmine. Effects of oleic acid enhancer. Drug Develop Res 1993, 28: 510-5.
12. Williams, F.M. Prediction of percutaneous penetration. Methods, measurement, modelling. In: Metabolism of Xenobiotics During Percutaneous Absorption. Scott, R.C., Guy, R.H., Hadgraft, H., Boddé, H.E. (Eds.). IBC Technical Services Ltd.: London 1991, 270-8.
13. Brodie, R.R., Chasseaud, L.F., Robbins, A.D. Determination of physostigmine in plasma by high performance liquid chromatography. J Chrom 1987, 415: 423-31.
14. Shah, V.P., Midha, K.K., Dighe, S. et al. Analytical methods validation. Bioavailability, bioequivalence, and pharmacokinetie studies. J Pharm Sci 1992, 81: 309-12.
15. Ellman, G.L. A new and rapid colorimetric determinantion of acetylcholinesterse activity. Biochem Pharmacol 1961, 7: 88-95.
16. Whelpton, R., Hurst, P. Bioavailability of oral physostigmine. New Engl J Med 1985, 313: 1293-94.
17. Whelpon, R., Moore, T. Sensitive liquid chromatographic method for physostigmine in biological fluids using dual-electrode electrochemical detection. J Chrom 1985, 341: 361-71.
18. Knapp, S., Wardlow, M.L. Thal, L.J. Sensitive analysis of plasma physostigmine levels using dual cell electrochemistry in the redox mode. J Chrom 1990, 526: 97-107.
19. Meyer, H.G., Lukey, B.J., Gepp, R.T., McLuskey, M.P., Lieske, C.N. Development and application of a radioimmunoassay for physostigmine. J Pharmacol Exp Ther 1989, 251: 606-11.
20. Miller, R.L., Venna, P.S. A radioimmunoassay for physostigmine in biological fluids and tissues. J Pharm Biomed Anal 1989, 7: 955-63.
21. Somani, S.M., Khalique, A. Pharmacokinetics and pharmacodynamics of physostigmine in the rat after intravenous administration. Drug Metab Dispos 1987, 15: 627-33.
22. Moriearty, P.L., Thornton, S.L., Becker, R.E. TD patch delivery of acetylcholinesterase inhibitors. Meth Find Exp Clin Pharmacol 1993, 15: 407-12.
23. Blick, D.W., Miller, S.A., Brown, G., Murphy, M.R. Behavioral toxicity of anticholinesterase in Primates: Chronic physostigmine and soman interactions. Pharmacol Biochem Behav 1993, 45: 677-83.
24. Pfeifer, S., Behnsen, G., Kühn, L. Stabilität von Alkaloiden in organischen Lösungsmitteln. Pharmazie 1972, 27 (10): 639-47.
25. Meshulain, Y., Davidivici, R., Wengier, A., Levy, A. Prophylactic transdermal treatment with physostigmine and scopolamine against soman intoxication in Guinea-pigs. J Appl Toxicol 1995, 15(4): 263-6.
26. Harris, L.W., Anderson, D.R., Lennox, W.J., Solana, R.P. Effects of subacute administration of physostigmine on blood acetylcholinesterase activity, motor performance, and soman intoxication. Toxicol Appl Pharm 1989, 97: 267-71.
27. Lennox, W.J., Harris, L.W., Talbot, B.G., Anderson, D.R. Relationship between reversible acetylcholinesterase inhibition anil efficacy against soman lethality. Life Sci 1985, 37: 793-8.
28. Benita, S., Friedman, D., Weinstock, M. Pharmacological evaluation of an injectable prolonged release emulsion of physostigmine in rabbits. J Pharm Pharmacol 1986, 38: 653-8.